NGM BIOPHARMACEUTICALS INC Quarterly Return On Assets in % from Q3 2019 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Ngm Biopharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q4 2023.
  • Ngm Biopharmaceuticals Inc Return On Assets for the quarter ending December 31, 2023 was -67.8 %, a 39.6% decline year-over-year.
  • Ngm Biopharmaceuticals Inc annual Return On Assets for 2023 was -67.8 %, a 39.6% decline from 2022.
  • Ngm Biopharmaceuticals Inc annual Return On Assets for 2022 was -48.5 %, a 70.1% decline from 2021.
  • Ngm Biopharmaceuticals Inc annual Return On Assets for 2021 was -28.5 %, a 5.12% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -67.8 -19.2 -39.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -61.8 -19 -44.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -60.4 -24.8 -69.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -57.4 -26.1 -83.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -48.5 -20 -70.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.8 -12.8 -42.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -35.7 -3.63 -11.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.3 -0.65 -2.12% Jan 1, 2022 Mar 31, 2022
Q4 2021 -28.5 +1.54 +5.12% Oct 1, 2021 Dec 31, 2021
Q3 2021 -30 -4.45 -17.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -32 -12.7 -65.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -30.6 -16.6 -118% Jan 1, 2021 Mar 31, 2021
Q4 2020 -30.1 -17.8 -146% Oct 1, 2020 Dec 31, 2020
Q3 2020 -25.6 -21.6 -537% Jul 1, 2020 Sep 30, 2020
Q2 2020 -19.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 -14 Jan 1, 2020 Mar 31, 2020
Q4 2019 -12.2 Oct 1, 2019 Dec 31, 2019
Q3 2019 -4.01 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.